174 related articles for article (PubMed ID: 23202893)
21. Expression of chemokine receptors on Th1/Th2 CD4+ lymphocytes in patients with multiple sclerosis.
Andalib A; Doulabi H; Najafi M; Tazhibi M; Rezaie A
Iran J Immunol; 2011 Mar; 8(1):1-10. PubMed ID: 21427490
[TBL] [Abstract][Full Text] [Related]
22. Antibodies against interferon-beta in neuromyelitis optica patients.
Asgari N; Kyvik KO; Steenstrup T; Stenager E; Lillevang ST
J Neurol Sci; 2014 Apr; 339(1-2):52-6. PubMed ID: 24477087
[TBL] [Abstract][Full Text] [Related]
23. IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis.
Xu W; Li R; Dai Y; Wu A; Wang H; Cheng C; Qiu W; Lu Z; Zhong X; Shu Y; Kermode AG; Hu X
J Neuroimmunol; 2013 Aug; 261(1-2):87-91. PubMed ID: 23726764
[TBL] [Abstract][Full Text] [Related]
24. Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis.
Norii M; Yamamura M; Iwahashi M; Ueno A; Yamana J; Makino H
Acta Med Okayama; 2006 Jun; 60(3):149-57. PubMed ID: 16838043
[TBL] [Abstract][Full Text] [Related]
25. Expression of TH1/TH2-related chemokine receptors on peripheral T cells and correlation with clinical disease activity in patients with multiple sclerosis.
Nakajima H; Fukuda K; Doi Y; Sugino M; Kimura F; Hanafusa T; Ikemoto T; Shimizu A
Eur Neurol; 2004; 52(3):162-8. PubMed ID: 15528917
[TBL] [Abstract][Full Text] [Related]
26. Neuromyelitis optica and asian phenotype of multiple sclerosis.
Kira J
Ann N Y Acad Sci; 2008 Oct; 1142():58-71. PubMed ID: 18990121
[TBL] [Abstract][Full Text] [Related]
27. Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?
Kim SH; Kim W; Li XF; Jung IJ; Kim HJ
Mult Scler; 2012 Oct; 18(10):1480-3. PubMed ID: 22354738
[TBL] [Abstract][Full Text] [Related]
28. Interferon alpha association with neuromyelitis optica.
Asgari N; Voss A; Steenstrup T; Kyvik KO; Stenager E; Lillevang ST
Clin Dev Immunol; 2013; 2013():713519. PubMed ID: 24348680
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of beta-interferon in Thai patients with demyelinating diseases.
Jarernsook B; Siritho S; Prayoonwiwat N
Mult Scler; 2013 Apr; 19(5):585-92. PubMed ID: 22968544
[TBL] [Abstract][Full Text] [Related]
30. Characterization of chemokine receptor expression and cytokine production in circulating CD4+ T cells from patients with atopic dermatitis: up-regulation of C-C chemokine receptor 4 in atopic dermatitis.
Okazaki H; Kakurai M; Hirata D; Sato H; Kamimura T; Onai N; Matsushima K; Nakagawa H; Kano S; Minota S
Clin Exp Allergy; 2002 Aug; 32(8):1236-42. PubMed ID: 12190665
[TBL] [Abstract][Full Text] [Related]
31. Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.
Feng X; Reder NP; Yanamandala M; Hill A; Franek BS; Niewold TB; Reder AT; Javed A
J Neurol Sci; 2012 Feb; 313(1-2):48-53. PubMed ID: 22036215
[TBL] [Abstract][Full Text] [Related]
32. [What are the unique characteristics of optico-spinal MS in Japanese and neuromyelitis optica in western populations].
Fukazawa T
Rinsho Shinkeigaku; 2006 Nov; 46(11):863-5. PubMed ID: 17432202
[TBL] [Abstract][Full Text] [Related]
33. Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein.
Herges K; de Jong BA; Kolkowitz I; Dunn C; Mandelbaum G; Ko RM; Maini A; Han MH; Killestein J; Polman C; Goodyear AL; Dunn J; Steinman L; Axtell RC
Mult Scler; 2012 Apr; 18(4):398-408. PubMed ID: 22343184
[TBL] [Abstract][Full Text] [Related]
34. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
35. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S
Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779
[TBL] [Abstract][Full Text] [Related]
36. Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
Wang KC; Tsai CP; Lee CL; Chen SY; Chin LT; Chen SJ
Neuroscience; 2012 Dec; 226():510-6. PubMed ID: 23122444
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
Warabi Y; Yagi K; Hayashi H; Matsumoto Y
J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
Matsuoka T; Matsushita T; Kawano Y; Osoegawa M; Ochi H; Ishizu T; Minohara M; Kikuchi H; Mihara F; Ohyagi Y; Kira J
Brain; 2007 May; 130(Pt 5):1206-23. PubMed ID: 17439988
[TBL] [Abstract][Full Text] [Related]
39. Abnormal expression of intracellular cytokines and chemokine receptors in peripheral blood T lymphocytes from patients with systemic sclerosis.
Fujii H; Hasegawa M; Takehara K; Mukaida N; Sato S
Clin Exp Immunol; 2002 Dec; 130(3):548-56. PubMed ID: 12452848
[TBL] [Abstract][Full Text] [Related]
40. [Neuromyelitis optica: the disease entity, pathogenesis and therapy].
Fujihara K
Rinsho Shinkeigaku; 2007 Nov; 47(11):883-5. PubMed ID: 18210826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
